At this time there is ample reason to suggest that particular cytokines (e.g., IL-6) and growth factors (e.g., BDNF) might serve as biomarkers in predicting who would be most prone to depression under various challenge conditions, and which treatment strategies would be most efficacious. This evidence concerns the gene IL6 and major depressive disorder.